Cite

HARVARD Citation

    Neal-Perry, G. et al. (2023). Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause. Obstetrics and gynecology. 141 (4), pp. 737-747. [Online]. 
  
Back to record